|
|
|
ARTICLES
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| |
| Health is Wealth: Challenges
of Financing a State of the Art
Pharmaceutical project in Africa
- Paul A. Lartey and Alexandra E.
Graham: It is very difficult
to attract financing for an
innovative pharmaceutical
manufacturing business in
sub-Saharan Africa. This
editorial relates some of our
experiences in that regard and
attempts to analyze the status quo
and at the same time draw attention
to the importance of financing
self-sufficient pharmaceutical
production as part of an overall
economic growth and poverty
reduction strategy - 1st GBC, Corporate
Africa Health Conference, 15-16
April, 2007, Accra, Ghana.
gbc1_article |
| |
|
The Challenge of Pharmaceutical
Manufacturing in Africa Improvements
through Regional Cooperation -
Paul A. Lartey, Ph.D. and Alexandra
E. Graham, Ph.D., MBA:
Excessive dependence on importation
of essential drugs threatens to
perpetuate the poor state of
healthcare in sub-Saharan Africa.
The need to establish a high quality
pharmaceutical manufacturing base
has long been acknowledged by NEPAD.
Nonetheless, the local industry
seriously lags behind in terms of
technology and quality standards.
Furthermore, the prevalence of fake
drugs and dumping by some foreign
manufacturers threaten the stability
and growth of the local industry -
2nd GBC Corporate Africa Health Conference,
Abuja, Nigeria, 2-4 Sept., 2008.
gbc2 abstract
|
| |
|
Studies on the Antifungal and
Antibacterial Properties of
Mycopirox - Omotayo Akanji,
Godfred Danso-Fadehan and An-Lammeh
Ketting: Mycopirox is a 1% aqueous
cream of the N-hydroxypyrone
ciclopirox olamine, topical
antifungal agent. The active
ingredient has been shown to be
superior to the azoles such as
miconazole, clotrimazole and
ketoconazole in that, unlike the
azoles, it is fungicidal,
bactericidal and has broad spectrum
activity against both fungi and
bacteria. In this study, we
compared the antimicrobial
properties of Mycopirox, as
formulated, with two leading brands
of miconazole cream, available in
West Africa. Our studies show that
Mycopirox is superior to the
‘leading azoles’, as it is rapidly
fungicidal and bactericidal at
applied doses and is potent against
both gram positive and gram negative
bacteria.
Annual General meeting,
Pharmaceutical Society of Ghana, ,
Tamale, Ghana, 13-16 August, 2008
psgagm_poster |
| |
| Building Capacity for Drug
Discovery, Development and
Manufacturing under cGMP Conditions
in West Africa - Paul A. Lartey,
Alexandra E. Graham and Omotayo
Akanji: Africa must build
capacity to discover, develop and
introduce innovative drugs for the
treatment of endemic diseases, in
order to help reduce the
disproportionate burden of disease
on the continent. A critical
component in this quest is the
engagement of a private sector with
the vision and mission to attain
self-sufficiency in pharmaceutical
development and commercialization.
We introduce ourselves as the first
local pharmaceutical manufacturer in
West Africa that has translated such
a vision into reality - 1st African
Network for Drug and Diagnostics
Innovation, Abuja, Nigeria 6-8
October, 2008.
andi_poster |
|
